Neurothera Labs Inc. (TSXV:NTLX)

Canada · Delayed Price · Currency is CAD

0.3250

+0.0350 (12.07%)

Aug 11, 2026, 1:26 PM EST

Neurothera Labs Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	0.86	0.86	1.31
Revenue Growth	-	-34.46%	-
Gross Profit	0.63	0.63	0.51
Operating Income	-2.74	-2.74	-2.81
Net Income	-4.12	-4.12	-2.94
Earnings Per Share	-0.06	-0.06	-0.05
EPS Growth	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	1.7	1.7	0.12
Total Debt	0.93	0.93	-
Net Cash (Debt)	0.77	0.77	0.12
Net Cash Growth	-	555.56%	-
Net Cash Per Share	0.01	0.01	0.00

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-1.66	-1.66	-1.69
Free Cash Flow	-1.66	-1.66	-1.69
Free Cash Flow Growth	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Gross Margin	73.72%	73.72%	38.74%
Operating Margin	-319.74%	-319.74%	-214.78%
Pretax Margin	-507.48%	-507.48%	-316.00%
Profit Margin	-481.66%	-481.66%	-225.27%

Valuation

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
PS Ratio	23.51	12.30	1.21